INNATE PHARMA (EPA:IPH) Innate Pharma (Euronext Paris: FR0010331421 – IPH) reports today its consolidated financial results for the year ending December 31, 2009 and updates on its drug candidates
Transparency directive : regulatory news
05/03/2010 06:28